San Francisco, CA — February 1, 2026 — TheraNovex, a global leader in clinical trial patient recruitment and retention solutions, today announced the launch of its groundbreaking Integrated Rideshare Technology. This innovative solution, powered by a strategic integration with Uber Health, is designed to eliminate one of the most significant hurdles in clinical research: patient transportation. By embedding seamless ride-hailing capabilities directly into the TheraNovex recruitment ecosystem, the company is addressing the logistical challenges that frequently lead to participant attrition and missed study visits.
Transportation remains a primary barrier to clinical trial diversity and retention, particularly for patients in underserved urban areas or those with mobility limitations. TheraNovex’s new platform addresses these inequities by providing a centralized, sponsor-funded transportation portal that requires no smartphone or app usage from the patient side, ensuring that participation is accessible to all demographics regardless of technological literacy or socio-economic status.
Key Features of the TheraNovex Rideshare Solution
- Seamless Ride Scheduling: Study coordinators can book on-demand or scheduled rides for participants directly through the TheraNovex dashboard, syncing perfectly with study visit windows.
- Real-Time Coordinator Tracking: Site staff gain a live bird’s-eye view of participant transit status, allowing clinics to optimize their daily workflows and prepare for patient arrival.
- Automated Appointment Reminders: The system sends multi-channel notifications (SMS and Voice) to patients, offering a pre-arranged ride as part of the visit reminder.
- Centralized Cost Management: Integrated financial tools allow sponsors to track transportation spend in real-time, with automated reimbursement workflows that eliminate manual paperwork.
- Multilingual Support: The interface and patient communications are available in over 15 languages to support global clinical programs.
How It Works: A Frictionless Experience
The TheraNovex Rideshare Technology is designed to function as a bridge between the clinical site and the patient’s home. When a patient is enrolled in a trial via the TheraNovex platform, their transportation needs are assessed during the onboarding phase. Once a study visit is scheduled, the platform automatically triggers a ride offer via the patient’s preferred communication channel.
Upon confirmation, the system coordinates with Uber Health to dispatch a driver at the appropriate time. Site coordinators receive a notification when the patient is en route, when they have arrived at the clinic, and when they are ready for their return trip. This end-to-end visibility ensures that the "last mile" of clinical trial participation is no longer a dark spot in the study timeline. Furthermore, the platform handles all backend billing, ensuring that the patient never has to pay out-of-pocket or navigate complex reimbursement forms.
Quantifiable Benefits for Sponsors and Sites
Early pilot programs utilizing the TheraNovex Rideshare Technology have demonstrated transformative results for clinical trial operations. Data collected over a twelve-month period across 40 global sites revealed a 35% reduction in patient no-show rates. By stabilizing the patient schedule, sites reported a 20% increase in overall operational efficiency, as staff spent less time rescheduling missed appointments and more time on high-value clinical tasks.
Beyond retention, the technology significantly bolsters recruitment efforts. Potential participants are more likely to enroll in a study when they are guaranteed reliable, safe, and free transportation. This has proven particularly effective in Phase II and Phase III trials involving elderly populations or patients with chronic conditions that make driving or navigating public transit difficult.
"The launch of our Integrated Rideshare Technology represents a pivotal shift in how we approach patient centricity. We aren't just finding patients for trials; we are ensuring they have the means to stay in them. By removing the stress of transportation, we are allowing patients to focus entirely on their health and their contribution to medical science. This is about equity, efficiency, and ultimately, accelerating the delivery of life-saving therapies to market."
— Dr. Emily Carter, CEO of TheraNovex
Uncompromising Compliance and Security
In the highly regulated world of clinical research, data integrity and patient privacy are paramount. TheraNovex has developed this integration with a "compliance-first" architecture. The platform is fully HIPAA-compliant and adheres to GDPR standards for international studies. By utilizing the Uber Health API, TheraNovex ensures that sensitive patient health information (PHI) is never shared with drivers. Drivers only receive the necessary pickup and drop-off information, while all clinical data remains encrypted within the TheraNovex secure environment.
Jennifer Walsh, VP of Regulatory Affairs at TheraNovex, emphasized the rigor of the system: "Our integration underwent exhaustive auditing to ensure it meets the highest standards of data security. We have successfully bridged the gap between consumer-grade convenience and clinical-grade security, ensuring that sponsors can provide this service with total confidence in their regulatory standing."
About TheraNovex
TheraNovex is a premier clinical trial patient recruitment and retention company headquartered in San Francisco. Combining cutting-edge data analytics with a human-centric approach, TheraNovex helps pharmaceutical and biotech companies reach their enrollment goals faster and more reliably. With a suite of proprietary tools ranging from AI-driven patient identification to integrated logistics management, TheraNovex is dedicated to modernizing the clinical trial experience for sponsors, sites, and patients alike.
Media Contact Information
Contact: Media Relations Team, TheraNovex
Email: press@theranovex.com
Phone: (555) 123-4567
Website: www.theranovex.com